Home > Insider Trading > Filing (0001209191-21-055478)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1087294	Cumberland Pharmaceuticals Inc	CPIX	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1408500	E Martin Cearnal	2525 West End Ave. Suite 950 Nashville TN 37203	Sr Vp/Chief Commercial Officer	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2021-08-02	105	$3.34	167,364	No	4	P	Direct
Common Stock	Acquisiton	2021-08-03	105	$3.17	167,469	No	4	P	Direct
Common Stock	Acquisiton	2021-08-04	105	$3.18	167,574	No	4	P	Direct
Common Stock	Acquisiton	2021-08-05	105	$3.11	167,679	No	4	P	Direct
Common Stock	Acquisiton	2021-08-06	105	$3.01	167,784	No	4	P	Direct
Common Stock	Acquisiton	2021-08-09	105	$2.93	167,889	No	4	P	Direct
Common Stock	Acquisiton	2021-08-10	105	$2.96	167,994	No	4	P	Direct
Common Stock	Acquisiton	2021-08-11	105	$2.98	168,099	No	4	P	Direct
Common Stock	Acquisiton	2021-08-13	105	$2.92	168,204	No	4	P	Direct
Common Stock	Acquisiton	2021-08-16	105	$2.92	168,309	No	4	P	Direct
Common Stock	Acquisiton	2021-08-17	105	$3.05	168,414	No	4	P	Direct
Common Stock	Acquisiton	2021-08-18	105	$2.97	168,519	No	4	P	Direct
Common Stock	Acquisiton	2021-08-19	105	$3.02	168,624	No	4	P	Direct
Common Stock	Acquisiton	2021-08-20	105	$2.96	168,729	No	4	P	Direct
Common Stock	Acquisiton	2021-08-23	105	$2.87	168,834	No	4	P	Direct
Common Stock	Acquisiton	2021-08-24	105	$2.89	168,939	No	4	P	Direct
Common Stock	Acquisiton	2021-08-25	105	$2.79	169,044	No	4	P	Direct
Common Stock	Acquisiton	2021-08-26	105	$2.82	169,149	No	4	P	Direct
Common Stock	Acquisiton	2021-08-27	105	$2.84	169,254	No	4	P	Direct
Common Stock	Acquisiton	2021-08-30	105	$2.88	169,359	No	4	P	Direct
Common Stock	Acquisiton	2021-08-31	105	$2.93	169,464	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct

Footnotes

The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.